Dan Lavallee

Dan LaVallee is a seasoned professional in transparency reporting and account management with extensive experience in the pharmaceutical and financial sectors. Currently serving as Director of Transparency Reporting at Genmab since April 2021, LaVallee previously held the position of Associate Director of Transparency Reporting at Ipsen Biopharmaceuticals from June 2016 to April 2021. With a strong background at Daiichi Sankyo, LaVallee contributed as Senior Manager in compiling state aggregate spend and transparency reports and as a Compliance Consultant in developing reporting systems for expenditures on healthcare professionals. Earlier career roles included Account Representative positions at Intercapital Plc, Liberty-Patriot Government Securities, and Garvin Guy Butler Corp, focusing on managing accounts and executing high-value trades. LaVallee holds an M.B.A. in Management from Fairleigh Dickinson University and a Bachelor of Science in Business Administration/Marketing Management from SUNY Brockport.